Carol R. Bradford, M.D. was elected in October 2014 to the prestigious Institute of Medicine of the National Academies (IOM), one of the highest honors in the fields of health and medicine. Individuals are elected to the IOM in recognition of their major contributions to the advancement of the medical sciences, health care and public health.
Dr. Bradford, chair of the Department of Otolaryngology-Head and Neck Surgery at the Medical School and the Charles J. Krause, M.D., Collegiate Professor of Otolaryngology, is an otolaryngologist and an internationally recognized leader in the treatment of head and neck cancer. She specializes in head and neck cancer surgery and reconstruction, as well as cutaneous oncology and sentinel lymph node biopsy. Her research focuses on identifying and evaluating biomarkers that can predict outcomes in head and neck cancer patients, and developing therapies to combat certain types of head and neck cancer that are resistant to traditional forms of treatment. Bradford has published more than 200 peer-reviewed articles.
During her 16-year tenure as co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center, she has helped to advance it from a small program with a few members to one with 30 members from 10 departments and five schools. She continues to play an active role within the program.
Bradford is one of six University of Michigan faculty elected to the IOM this year. Her fellow honorees include Gonçalo Abecasis, D.Phil.; Eva Feldman, M.D.; A. Mark Fendrick, M.D.; Susan Murphy, Sc.D., OTR; and Kathleen Potempa, Ph.D., R.N. With their election, the University of Michigan now has 59 past and present members of the IOM.